2026 NPPES data Dermatology Physician NPI 1891708590 MD
Verify on CMS →

ROBERT GIELCZYK, MD

Dermatology Physician in NORTON SHORES, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 1K beneficiaries · Dermatology Physician avg: 729
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.2504/100
▲ 7 pts above national avg 83.1 · [object Object]
Industry payments
$397.76
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ROBERT GIELCZYK, MD reported a CMS MIPS final score of 90.2504/100 — above the 83.1 national average — and filed 5,155 Medicare Part D claims in 2023.

90.2504/100
MIPS score · +7 vs avg
5K
Part D claims, 2023
95%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBERT GIELCZYK, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 40% higher than 60% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ROBERT GIELCZYK, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ROBERT GIELCZYK, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/14/2006

NPI 1891708590

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

5,155 607% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

90.2504/100 7.150400000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Michigan

How Dermatology Physician compares to other specialties among Michigan providers

Michigan providers

Dermatology Physician share within Michigan

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Michigan

Medicare quality performance — MIPS

ROBERT GIELCZYK, MD's 2023 MIPS final score plotted against the Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
90.2504/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 90.2504/100 vs national avg 83.1

0%100%National avg83%90.3%
MIPS final score (Dermatology Physician) — 90.2504/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT GIELCZYK, MD is a Dermatology Physician provider practicing in NORTON SHORES, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1891708590. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT GIELCZYK, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 6225 PRAIRIE ST, NORTON SHORES, MI, 49444, with a listed phone of (231) 798-9500. NPI 1891708590 was issued on 08/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GIELCZYK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,155 prescription claims written by this provider, covering 1,390 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.2504/100 for the 2023 performance year (Quality 98.6458, Cost 69.3069), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6225 PRAIRIE ST
NORTON SHORES, MI 49444

Provider Details

NPI 1891708590
Specialty Dermatology Physician
Credentials MD
Gender Male
NPI Issued 08/14/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.2504
Final Score
Avg: 83.1
98.6458
Quality
69.3069
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where ROBERT GIELCZYK, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FOREFRONT DERMATOLOGY SC
MARQUETTE, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT GIELCZYK, MD. Source: openpaymentsdata.cms.gov.

Total received

$398

Largest payer

Arcutis Biotherapeutics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to ROBERT GIELCZYK, MD. To verify ROBERT GIELCZYK, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ROBERT GIELCZYK, MD — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 5,155 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,155
Total Claims
$1.9M
Total Drug Cost
1,390
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,922
Total Day Supply
185,156
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$1.7M
Generic Drug Cost
$203K
Antibiotic Claims
620

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.11
Gender Split
58% female / 42% male
Age Distribution
<65: 156, 65-74: 652, 75-84: 461, 85+: 121

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Clobetasol Propionate
921
Betamethasone Dipropionate
519
Triamcinolone Acetonide
396
Minoxidil
385
Finasteride
364
Minocycline Hcl
359
Metronidazole
204
Ketoconazole
194
Doxycycline Hyclate
157
Methotrexate
Methotrexate Sodium
113

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How ROBERT GIELCZYK, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

ROBERT GIELCZYK, MD's 5,155 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as GIELCZYK.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT GIELCZYK, MD's specialty?
ROBERT GIELCZYK, MD specializes in Dermatology Physician and practices in NORTON SHORES, Michigan. Credentials: MD.
How much does ROBERT GIELCZYK, MD prescribe under Medicare Part D?
In 2023, ROBERT GIELCZYK, MD wrote 5,155 Medicare Part D claims totaling $1.9M in drug costs for 1,390 beneficiaries.
What is ROBERT GIELCZYK, MD's Medicare quality score?
ROBERT GIELCZYK, MD has a CMS MIPS Final Score of 90.2504/100 (Quality: 98.6458, Cost: 69.3069). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT GIELCZYK, MD located?
ROBERT GIELCZYK, MD is located at 6225 PRAIRIE ST, NORTON SHORES, MI, 49444. Phone: (231) 798-9500.
What is ROBERT GIELCZYK, MD's NPI number?
ROBERT GIELCZYK, MD's National Provider Identifier (NPI) is 1891708590, issued on 08/14/2006.
Does ROBERT GIELCZYK, MD prescribe more brand-name or generic drugs?
ROBERT GIELCZYK, MD's prescribing is 5% brand-name and 95% generic drugs by claim count, with $1.7M in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does ROBERT GIELCZYK, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT GIELCZYK, MD's most frequently prescribed drugs include Clobetasol Propionate, Betamethasone Dipropionate, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT GIELCZYK, MD accept Medicare?
ROBERT GIELCZYK, MD appears in CMS Medicare data with 5,155 Part D claims and 1,390 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT GIELCZYK, MD's credentials?
ROBERT GIELCZYK, MD's NPI is 1891708590 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology